ACIP June 2013 Meeting Agenda 1 of 2

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

Centers for Disease Control and Prevention

1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Kent “Oz” Nelson Auditorium

Atlanta, Georgia 30333

June 19-20, 2013

Wednesday, June 19, 2013

AGENDA ITEM PURPOSE PRESIDER/PRESENTER(s)

8:00 am to 8:30 am Welcome & Introductions Dr. Jonathan Temte (ACIP Chair)

Dr. Larry Pickering (Executive Secretary, ACIP)

8:30 am to 8:45 am

Agency Updates

CDC, CMS, DoD, DVA, FDA, HRSA, HIS, NVPO, NIH

8:45 am to 10:30 am Japanese Encephalitis Vaccine

Introduction

Safety and immunogenicity of JE-VC in children

GRADE evidence for JE-VC in children

Recommendations for use of JE-VC in children

Information & 

Discussion

Vote

Dr. Joseph Bocchini (ACIP, WG Chair)

Dr. Katrin Dubischar-Kastner (Intercell Biomed.) 

Dr. Marc Fischer (CDC/NCEZID) 

Dr. Marc Fischer (CDC/NCEZID) 

10:30 am to 11:00 am Break

11:00 am to 11:45 pm General Recommendations on Immunization

Overview

Preventing and managing adverse reactions

Information & 

Discussion

Dr. Jeff Duchin (ACIP, WG Chair)

Dr. Andrew Kroger (CDC/NCIRD)

11:45 pm to 1:00 pm Lunch

1:00 pm to 3:30 pm Pertussis Vaccines

Introduction

Pertussis in the United States and Tdap vaccine

effectiveness

Tdap revaccination: safety and immunogenicity

 Decision and cost effectiveness analysis: a second dose of 

Tdap

 Work group conclusions on a second dose of Tdap

Information & 

Discussion

Dr. Mark Sawyer (ACIP, WG Chair)

Dr. Anna Acosta (CDC/NCIRD)

Dr. Jennifer Liang (CDC/NCIRD)

Dr. Mark Messonnier, Dr. Hajime Kamiya 

(CDC/NCIRD) 

Dr. Jennifer Liang (CDC/NCIRD)

3:30 pm to 4:00 pm Break

4:00 pm to 5:15 pm Human Papillomavirus (HPV) Vaccines 

Introduction

Merck pregnancy registry for quadrivalent HPV vaccine

Plans for updated ACIP statement

HPV vaccine impact monitoring

Information & 

Discussion

Dr. Joseph Bocchini (ACIP, WG Chair)

Dr. Fabio Lievano (Merck) 

Dr. Eileen Dunne (CDC/NCHHSTP)

Dr. Lauri Markowitz (CDC/NCHHSTP) 

5:15 pm to 5:30 pm Public Comment

5:30 pm Adjourn

 Maternal Tdap and cocooning: experiences from Australia

and the United Kingdom

Dr. Peter McIntyre (National Center for 

Immunization Resrch & Surv., Australia) 

Dr. David Salisbury (Department of 

Health, United Kingdom) 

Final - June 13, 2013
ACIP June 2013 Meeting Agenda 2 of 2

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

Centers for Disease Control and Prevention

1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Kent “Oz” Nelson Auditorium

Atlanta, Georgia 30333

June 19-20, 2013

 

Thursday, June 20, 2013

AGENDA ITEM PURPOSE PRESIDER/PRESENTER(s)

8:00 am to 8:15 am Unfinished Business Dr. Jonathan Temte (ACIP Chair)

8:15 am to 10:45 am Rotavirus Vaccines: Update on Intussusception

Introduction: intussusception following RV5 and RV1

VSD data

VAERS data

PRISM data

Australian data

Summary and review of risk: benefit in the United States

Information & 

Discussion

Dr. Marietta Vázquez (ACIP, WG Chair)

Mr. Eric S. Weintraub, MPH (CDC/NCEZID)

Ms. Penina Haber, MPH (CDC/NCEZID)

Dr. Katherine Yih (Harvard Pilgrim Health Care 

Institute)

Dr. Peter McIntyre (National Center for 

Immunization Resrch. & Surv., Australia) 

Dr. Margaret Cortese (CDC/NCIRD)

10:45 am to 11:15 am Break

11:15 am to 11:45 am The Role of Retail Pharmacies/Pharmacists in Vaccine 

Delivery in the United States

Information & 

Discussion

Mr. Mitchel C. Rothholz, RPh, MBA (American 

Pharmacists Association)

11:45 am to 11:50 am Vaccine Supply Information & 

Discussion Dr. Jeanne Santoli (CDC/NCIRD) 

11:50 am to 12:00 pm

Herpes Zoster Vaccine

Update on Herpes Zoster Work Group activities Information Dr. Jeff Duchin (ACIP, WG Chair)

12:00 pm to 1:00 pm Lunch

1:00 pm to 3:00 pm Influenza

Introduction

Epidemiology/surveillance update

H7N9 update

Preliminary data on 2012-2013 vaccine effectiveness

Vaccine safety update

FluLaval Quadrivalent: GSK's inactivated quadrivalent 

 seasonal influenza vaccine manufactured in Quebec

 2013-2014 recommendations

Information & 

Discussion

Vote

Dr. Wendy Keitel (ACIP, WG Chair)

Dr. Lyn Finelli (CDC/NCIRD) 

Dr. Dan Jernigan (CDC/NCIRD) 

Dr. Mark Thompson (CDC/NCIRD)

Dr. Tom Shimabukuro (CDC/NCEZID)

Dr. Varsha Jain (GlaxoSmithKline)

Dr. Lisa Grohskopf (CDC/NCIRD) 

3:00 pm to 3:15 pm Public Comment

3:15 pm Adjourn

Final - June 13, 2013